Bicyclic Sulfonamide Compounds as Sodium Channel Inhibitors
申请人:AMGEN INC.
公开号:US20160137636A1
公开(公告)日:2016-05-19
The present invention provides compounds of Formula I or pharmaceutically acceptable salts thereof, that are inhibitors of voltage-gated sodium channels, in particular Nav1.7. The compounds are useful for the treatment of diseases treatable by inhibition of sodium channels such as pain disorders. Also provided are pharmaceutical compositions containing compounds of the present invention.